Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
CX4-H5219 | Human | Human CXCR4 / CD184 Full Length Protein-VLP (HEK293) |
![]() ![]() |
||
CX4-H5269 | Human | Human CXCR4 / CD184 Protein, Fc Tag | ![]() |
![]() ![]() |
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Plerixafor | SDZ-SID-791; JM-3100; JKL-169; AMD-3100; PLR-001 | Approved | Genzyme Corp | 释倍灵, Mozobil, Mobozil | Mainland China | Lymphoma, Non-Hodgkin; Multiple Myeloma | Genzyme Europe Bv | 2008-12-15 | Hematopoietic stem cell transplantation (HSCT); Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Hodgkin Disease; Kidney Diseases; Myelodysplastic Syndromes; Rejection of organ transplantation; Multiple Myeloma; Neuroblastoma; Brain Neoplasms; Sarcoma, Ewing; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Lymphoma, Non-Hodgkin; Leukemia, Myeloid, Acute; Lymphoma; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Ulocuplumab | MDX-1338; BMS-936564 | Phase 2 Clinical | Bristol-Myers Squibb Company | Leukemia; Solid tumours; Pancreatic Neoplasms; Small Cell Lung Carcinoma; Multiple Myeloma; Lymphoma, Follicular; Leukemia, B-Cell; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
NRP-2945 | NNZ-4945; NRP-2945 | Phase 2 Clinical | Neuren Pharmaceuticals | Epilepsy | Details |
Balixafortide | POL-6326 | Phase 3 Clinical | Polyphor Ltd | Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Myelodysplastic Syndromes; Myeloproliferative Disorders; Multiple Myeloma; Breast Neoplasms; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Leukemia, Myeloid, Acute; Leukemia, Lymphocytic, Chronic, B-Cell | Details |
GMI-1359 | GMI-1359 | Phase 1 Clinical | Glycomimetics Pharmaceutical | Breast Neoplasms; Metastatic breast cancer | Details |
X-4136 | X-4136 | Clinical | X4 Pharmaceuticals | Lymphoma, B-Cell | Details |
PTX-9908 | PTX-9908 | Phase 2 Clinical | Pertinax Therapeutics | Liver Neoplasms; Carcinoma, Hepatocellular | Details |
LY-2510924 | T-134; LY-2510924 | Phase 2 Clinical | Eli Lilly And Company | Solid tumours; Carcinoma, Renal Cell; Small Cell Lung Carcinoma | Details |
AD-214 | AD-214 | Phase 1 Clinical | Lung Diseases, Interstitial; Gastroesophageal Reflux | Details | |
MSX-122 | Q-122; WZ-40; MSX-122 | Phase 2 Clinical | Altiris Therapeutics | Vasomotor symptom; Solid tumours; Hot Flashes | Details |
Motixafortide | BKT-140; BL-8040; TF-14016; TN-14003; 4F-Benzoyl-TN14003 | Phase 3 Clinical | Biokine | Hematopoietic stem cell transplantation (HSCT); Esophageal Neoplasms; Pancreatic Neoplasms; Myelodysplastic Syndromes; Multiple Myeloma; Anemia, Aplastic; Leukemia, Myeloid, Acute; Carcinoma, Non-Small-Cell Lung | Details |
JVS-100 | SRX-100; ACRX-100; GP-51801; GP51801; JVS-100 | Phase 2 Clinical | Cleveland Clinic | Heart Failure; Ischemia; Peripheral Arterial Disease | Details |
[68Ga]Pentixafor | Phase 2 Clinical | The University Of Iowa | Central Nervous System Neoplasms; Neuroendocrine Tumors; Diagnostic agents | Details | |
Mavorixafor | AMD-11070; X4P-001-IO; AMD-070; X4P-001; X4P-001-RD; X4P-001-LD; ABSK-081 | Phase 3 Clinical | Genzyme Corp | HIV Infections; WHIM syndrome; Neutropenia; Carcinoma, Renal Cell; Triple Negative Breast Neoplasms; Waldenstrom Macroglobulinemia; Melanoma | Details |
This web search service is supported by Google Inc.